October 11, 2022
Anticipated Publication Date of Challenge Announcement: December 1, 2022
Anticipated Submission Start Date: December 1, 2022
Anticipated Submission Due Date: May 31, 2023
Anticipated Award Date: August 25, 2023
Related Announcements
There are no related notices.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) intends to publish a prize competition announcement to solicit entries for the 2023 DEBUT (Design by Biomedical Undergraduate Teams) Challenge. Started in 2012, NIBIB’s annual DEBUT Challenge has solicited design projects that develop innovative solutions to unmet health and clinical problems. Areas of interest for the biomedical engineering projects include, but are not limited to: diagnostics, therapeutics, technologies for underserved populations or low-resource settings, point-of-care systems, precision medicine, preventive medicine, technologies to aid individuals with disabilities, and technologies for the prevention, diagnosis, treatment, and care of diseases and illnesses such as cancer or HIV/AIDS.
This Notice is being provided to inform potential student teams of the upcoming opportunity to compete in the 2023 DEBUT Challenge. Publication of the Challenge announcement and launch of the submission portal are planned for December 1, 2022. The estimated submission deadline is May 31, 2023.
In 2023, NIBIB intends to award a total of up to $125,000 in cash prizes. Additional information about the planned prize competition is included below.
Background
By challenging undergraduate students to identify unmet clinical needs and develop innovative solutions for them, NIBIB targets the education of biomedical engineers who have the background, skills, and confidence to make outstanding contributions to biomedical technologies. Engaging undergraduate students to work in teams to design, build and debug solutions to real-world problems/needs in healthcare not only prepares them to function effectively in their future work environment, but also yields novel, innovative biomedical tools that can transform healthcare.
Prize Competition Details
As in previous years, DEBUT 2023 is intended to be a design competition that challenges teams of undergraduate students to identify unmet needs in healthcare and design engineering solutions for them. All aspects of the 2023 DEBUT Challenge are expected to be similar to those of the 2022 DEBUT challenge, the details for which can be found at https://www.nibib.nih.gov/research-programs/DEBUT-challenge/DEBUT-2021-announcement. Additionally, in DEBUT 2023, a new prize is expected to be awarded for entries that develop technologies to empower nurses in community settings.
To support and expand the DEBUT Challenge, the NIBIB has joined forces with VentureWell, a not-for-profit leader in funding, training, coaching and early investment that brings student innovations to market. This public-private partnership on DEBUT allows student teams to compete for prizes offered by both NIBIB and VentureWell by submitting one application. As in previous DEBUT Challenges, NIBIB expects student teams entering the DEBUT Challenge to have the option for their entries to also be considered for prizes offered by VentureWell. VentureWell prizes will be selected and awarded by VentureWell following a separate judging process. The rules for the VentureWell prizes and the additional submission components required are expected to be similar to those of past DEBUT challenges and can be found at:http://venturewell.org/students/debut/guidelines.
The Challenge announcement will likely be posted on multiple websites, including Challenge.gov and the NIBIB DEBUT website, and broadly disseminated across NIH stakeholder networks.
NIBIB intends to conduct this Challenge under the authority provided by the America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science (COMPETES) Reauthorization Act of 2010, as amended [15 U.S.C. § 3719].
SUBMISSIONS ARE NOT BEING SOLICITED AT THIS TIME.
Dave Gutekunst, Ph.D.
National Institute of Biomedical Imaging and Bioengineering
Division of Interdisciplinary Training
Telephone: 301-402-5069
Email: dave.gutekunst@nih.gov
and Human Services (HHS)
